In a previous study, we found a differentially methylation region (DMR) at MHC HLA-DRB1 that was associated within relapsing-remitting MS (RRMS) patients in CD4+ T cells. This evidence concerns the gene HLA-DRB1 and relapsing-remitting multiple sclerosis.